干扰素信号制约细胞癌异质性的脏细胞癌
Peter Holicek1, Jitka Fucikova1, Lorenzo Galluzzi2
1Sotio Biotech a.s., Prague, Czech Republic; Second Medical Faculty, Charles University, Prague, Czech Republic.
Trends in cancer
|September 1, 2023
概括
一类干扰素 (IFN) 信号抑制癌的进展. 这一途径抑制了癌细胞的发展.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- I型干扰素 (IFN) 在癌症监测中起着至关重要的作用.
- IFN通过直接和免疫驱动的瘤抑制作用对瘤进行调解.
研究的目的:
- 研究IFN信号传导在调节癌细胞适应染色体不稳定 (CIN) 的作用.
- 了解IFN如何影响癌的转移潜力.
主要方法:
- 对癌细胞系的分析.
- 对染色体不稳定性 (CIN) 耐受性的评估.
- 对IFN信号通路的评估.
主要成果:
- IFN信号负面调节癌细胞耐受CIN的能力.
- 抑制的IFN信号与对心型变化的增强耐受性相关.
- 抑制IFN通路可能会促进瘤转移的潜力.
结论:
- IFN信号传递是癌适应CIN的关键抑制剂.
- 准IFN通路可能会影响癌的进展和转移.
相关概念视频
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K


